Table 2.
Sham | ACF | Sham+Allopurinol | ACF+Allopurinol | |
---|---|---|---|---|
LVESD (mm) | 3.54±0.3 | 3.1±0.3 | 3.1±0.42 | 3.5±0.2 |
LVEDD (mm) | 6.4±0.2 | 6.7±0.3* | 6.4±0.3 | 7±0.1* |
LVESV (µL) | 90±9 | 92±17 | 69±14 | 95±13 |
LVEDV (µL) | 326±17 | 389±26 | 308±22 | 364±18 |
EF (%) | 73±2 | 77±3 | 77±4 | 74±3 |
LVPWs (mm) | 2.8±0.1 | 3±0.2 | 3±0.2 | 2.7±0.1 |
LVPWd (mm) | 1.8±0.1 | 1.8±0.2 | 1.8±0.1 | 1.5±0.03 |
LVES σ | 43±7 | 23±4* | 34±11 | 32±4* |
LVED σ | 2.5±0.2 | 8±1.1* | 4±1.5 | 5±0.6*§ |
LV ESPVR | 1.48±0.2 | 0.36±0.07* | 1.62±0.26 | 0.71±0.07*§ |
N | 7 | 8 | 6 | 8 |
LV end-systolic dimension (LVESD), LV end-diastolic dimension (LVEDD), LVES volume (LVESV), LVEDV, LV Ejection Fraction (EF), LVES Posterior wall thickness (LVPWs), LVED Posterior wall thickness (LVPWd) LVES wall stress (σ) LVED σ, LV ES Pressure-Volume
Relationship*= P<0.05 vs Sham,
P<0.05 vs ACF, data = mean ± SE